Advaxis Discusses Global Licensing Agreement for Pet Therapeutics on …

Published March 20, 2014

Advaxis Discusses Global Licensing Agreement for Pet Therapeutics on …
ADXS-HPV, Advaxis's lead immunotherapy for the treatment of HPV-associated cancers, has demonstrated improved survival and objective tumor responses in a Phase 2 trial in 110 patients with recurrent cervical cancer. … ADXS-HPV has orphan drug status …
Read more on Wall Street Journal

Could snake venom help deal with major health care crisis?
A “nightmare” superbug, resistant to most antibiotics, is spreading throughout hospitals and nursing homes in the United States, an official with the federal Centers for Disease Control and Prevention (CDC) warned earlier this month. Could snake venom …
Read more on The Daily Citizen

Find More Drug Treatment Center Georgia Information…